The Effect of Hypericum Perforatum L. on Severity of Early Menopause Symptoms
Objective: Menopause might lead to physical, mental problems for women and also disruption theirlife quality. Despite the existance of a single treatment to remove the disorders, herbal medicine is referable to chemical one in that they alleviate the related symptoms. The present research study aims to investigate the effect of Hypericum Perforatum L. on severity of early symptoms of menopause. Materials and Method: This double blind clinical trial study was conducted on 70 menopause women (two 35-person groups) picked out by a purposive sampling procedure. The first group received 160 mg Hypericum Perforatum L. (Perforin pill) while the second one received a placebo (ineffective pill). Menopause symptoms of 2, 4, 6, and 8 weeks after taking the pill or placebo were recorded in the 'Kupperman index' for menopause symptoms. The gathered data were then analyzed via independent t-test, one-way ANOVA, and repeated measure variance. Significance level was P≤0.05. Results: The age average in the medicine group was 50.49±2.74 and in the placebo group was 50.63±2.87. Body Mass Index (BMI) showed an overweight in both groups (27.29±0.75, 27.23±0.64). Furthermore, comparing the 'Kupperman index'for symptoms between the two groups in 6, 4, and 8 weeks after intervention revealed that the Hypericum Perforatum L. significantly had positive effects on alleviation of eraly menopause symptoms compared to placebo (P≤0.001). Conclusion: The results indicated that Hypericum Perforatum L. might alleviate the severity of early menopause symptoms. Thus, given its being economical and also its slight side effects, it is recommended as a suitable and desirable replacement for counterpart chemical medicine.
Copyright (c) 2019 International Journal of Ayurvedic Medicine
This work is licensed under a Creative Commons Attribution 4.0 International License.
The author hereby transfers, assigns, or conveys all copyright ownership to the International Journal of Ayurvedic Medicine (IJAM). By this transfer, the article becomes the property of the IJAM and may not be published elsewhere without written permission from the IJAM.
This transfer of copyright also implies transfer of rights for printed, electronic, microfilm, and facsimile publication. No royalty or other monetary compensation will be received for transferring the copyright of the article to the IJAM.
The IJAM, in turn, grants each author the right to republish the article in any book for which he or she is the author or editor, without paying royalties to the IJAM, subject to the express conditions that (a) the author notify IJAM in advance in writing of this republication and (b) a credit line attributes the original publication to IJAM.